Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Quantifying myocardial inflammation using F18-fluorodeoxyglucose positron emission tomography in cardiac sarcoidosis.

Literature DB >> 24942609

Quantifying myocardial inflammation using F18-fluorodeoxyglucose positron emission tomography in cardiac sarcoidosis.

Alfonso H Waller¹, Ron Blankstein.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Fluorodeoxyglucose F18

Year: 2014 PMID： 24942609 DOI： 10.1007/s12350-014-9921-5

Source DB: PubMed Journal: J Nucl Cardiol ISSN： 1071-3581 Impact factor: 5.952

× No keyword cloud information.

9 in total

1. Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis.

Authors: Azadeh Ahmadian; Ashley Brogan; Jeffrey Berman; Aaron L Sverdlov; Gustavo Mercier; Michael Mazzini; Praveen Govender; Frederick L Ruberg; Edward J Miller
Journal: J Nucl Cardiol Date: 2014-05-31 Impact factor: 5.952

2. Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?

Authors: Brian A Mc Ardle; David H Birnie; Ran Klein; Rob A de Kemp; Eugene Leung; Jennifer Renaud; Jean DaSilva; George A Wells; Rob S Beanlands; Pablo B Nery
Journal: Circ Cardiovasc Imaging Date: 2013-07-24 Impact factor: 7.792

3. Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics.

Authors: Michael C Iannuzzi; Joseph R Fontana
Journal: JAMA Date: 2011-01-26 Impact factor: 56.272

4. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis.

Authors: Nobuhiro Tahara; Atsuko Tahara; Yoshikazu Nitta; Norihiro Kodama; Minori Mizoguchi; Hayato Kaida; Kenkichi Baba; Masatoshi Ishibashi; Naofumi Hayabuchi; Jagat Narula; Tsutomu Imaizumi
Journal: JACC Cardiovasc Imaging Date: 2010-12

5. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.

Authors: Wataru Okumura; Tsutomu Iwasaki; Takuji Toyama; Tatsuya Iso; Masashi Arai; Noboru Oriuchi; Keigo Endo; Tomoyuki Yokoyama; Tadashi Suzuki; Masahiko Kurabayashi
Journal: J Nucl Med Date: 2004-12 Impact factor: 10.057

6. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.

Authors: Ron Blankstein; Michael Osborne; Masanao Naya; Alfonso Waller; Chun K Kim; Venkatesh L Murthy; Pedram Kazemian; Raymond Y Kwong; Michifumi Tokuda; Hicham Skali; Robert Padera; Jon Hainer; William G Stevenson; Sharmila Dorbala; Marcelo F Di Carli
Journal: J Am Coll Cardiol Date: 2013-10-16 Impact factor: 24.094

7. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis.

Authors: K J Silverman; G M Hutchins; B H Bulkley
Journal: Circulation Date: 1978-12 Impact factor: 29.690

8. Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.

Authors: Michael T Osborne; Edward A Hulten; Avinainder Singh; Alfonso H Waller; Marcio S Bittencourt; Garrick C Stewart; Jon Hainer; Venkatesh L Murthy; Hicham Skali; Sharmila Dorbala; Marcelo F Di Carli; Ron Blankstein
Journal: J Nucl Cardiol Date: 2013-12-03 Impact factor: 5.952

9. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis.

Authors: Hiroshi Ohira; Ichizo Tsujino; Shinji Ishimaru; Noriko Oyama; Toshiki Takei; Eriko Tsukamoto; Masatake Miura; Shinji Sakaue; Nagara Tamaki; Masaharu Nishimura
Journal: Eur J Nucl Med Mol Imaging Date: 2007-12-15 Impact factor: 9.236

9 in total

1. Quantifying FDG uptake to diagnose cardiac device infections: When and how should we do it?

Authors: Ron Blankstein; Edward J Miller
Journal: J Nucl Cardiol Date: 2015-10-22 Impact factor: 5.952

Review 2. Recommendations for ¹⁸F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update: Japanese Society of Nuclear Cardiology recommendations.

Authors: Shinichiro Kumita; Keiichiro Yoshinaga; Masao Miyagawa; Mitsuru Momose; Keisuke Kiso; Tokuo Kasai; Masanao Naya
Journal: J Nucl Cardiol Date: 2019-08 Impact factor: 5.952

3. Joint SNMMI-ASNC expert consensus document on the role of ¹⁸F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring.

Authors: Panithaya Chareonthaitawee; Rob S Beanlands; Wengen Chen; Sharmila Dorbala; Edward J Miller; Venkatesh L Murthy; David H Birnie; Edward S Chen; Leslie T Cooper; Roderick H Tung; Eric S White; Salvador Borges-Neto; Marcelo F Di Carli; Robert J Gropler; Terrence D Ruddy; Thomas H Schindler; Ron Blankstein
Journal: J Nucl Cardiol Date: 2017-10 Impact factor: 5.952

4. Cardiac sarcoidosis: An important niche for PET, but a journey just begun.

Authors: Timothy M Bateman
Journal: J Nucl Cardiol Date: 2016-08-09 Impact factor: 5.952

5. A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology.

Authors: Riemer H J A Slart; Andor W J M Glaudemans; Patrizio Lancellotti; Fabien Hyafil; Ron Blankstein; Ronald G Schwartz; Wael A Jaber; Raymond Russell; Alessia Gimelli; François Rouzet; Marcus Hacker; Olivier Gheysens; Sven Plein; Edward J Miller; Sharmila Dorbala; Erwan Donal
Journal: J Nucl Cardiol Date: 2018-02 Impact factor: 5.952

6. The logic and challenges of imaging sarcoidosis with whole body FDG PET.

Authors: Roberto C Valentin; Pradeep Bhambhvani
Journal: J Nucl Cardiol Date: 2017-08-17 Impact factor: 5.952

7. Joint SNMMI-ASNC Expert Consensus Document on the Role of ¹⁸F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring.

8. Proceedings of the ASNC cardiac PET summit meeting, May 12 2014, Baltimore MD : 4. Novel applications of cardiovascular PET.

Authors: Ron Blankstein; Justin Lundbye; Gary Heller
Journal: J Nucl Cardiol Date: 2015-07-22 Impact factor: 5.952

9. The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis.

Authors: Azadeh Ahmadian; Sumeet Pawar; Praveen Govender; Jeffrey Berman; Frederick L Ruberg; Edward J Miller
Journal: J Nucl Cardiol Date: 2016-07-25 Impact factor: 5.952

9 in total

Review 2. Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update: Japanese Society of Nuclear Cardiology recommendations.

Review 2. Recommendations for ¹⁸F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update: Japanese Society of Nuclear Cardiology recommendations.